These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14128980)

  • 1. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 2. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 3. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 4. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 5. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 6. NEUROVIRULENCE FOR MONKEYS OF SABIN'S TYPE 1 POLIOVIRUS PASSED THROUGH HUMAN INTESTINES AS COMPARED WITH ATTENUATED AND VIRULENT POLIOVIRUS STRAINS.
    SIMON J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():506-15. PubMed ID: 14238949
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of homologous and heterologous complement-fixing antibodies against poliomyelitis after oral vaccination with Sabin's live vaccine].
    Altevogt R
    Z Immunitatsforsch Allerg Klin Immunol; 1965 Sep; 129(3):296-301. PubMed ID: 4223286
    [No Abstract]   [Full Text] [Related]  

  • 8. THE REDUCTION OF WILD POLIOVIRUS CIRCULATION FOLLOWING VACCINATION WITH THE LIVE VACCINE. A NEW FACTOR IN THE OECOLOGY OF ENTERIC VIRUSES?
    PESEK J; VOBECKY J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():262-3. PubMed ID: 14184882
    [No Abstract]   [Full Text] [Related]  

  • 9. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 10. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
    Assumma M; Russo V; Alemanno A
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):175-86. PubMed ID: 5615073
    [No Abstract]   [Full Text] [Related]  

  • 12. ENTEROVIRUS TYPING BY COMPLEMENT FIXATION.
    GNESH GM; PLAGER H; DECHER W
    Proc Soc Exp Biol Med; 1964 Apr; 115():898-900. PubMed ID: 14166601
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.
    SLONIM D; MARES I; DREVO M; STURMOVA H; SIMON J
    Bull World Health Organ; 1962; 26(3):331-9. PubMed ID: 13913913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 15. [COMPARATIVE ATTEMPTS TO DEMONSTRATE ANTIBODIES AGAINST POLIOMYELITIS VIRUS WITH THE NEUTRALIZATION TEST AND THE IMMUNOFLUORESCENCE METHOD].
    BOSELLA F
    Boll Ist Sieroter Milan; 1964; 43():249-52. PubMed ID: 14199041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sabin's oral vaccine with living virus against polio in Czechoslovakia. Its effectiveness in world-wide use in 1960].
    SKOVRANE V; ZACEK DE PRAGA K
    Rev Cubana Pediatr; 1962; 24():75-8. PubMed ID: 13913703
    [No Abstract]   [Full Text] [Related]  

  • 17. [ISOLATED FACIAL PARALYSIS IN CHILDHOOD (CASE CONTRIBUTION). I. VIROLOGICAL AND SEROLOGICAL RESEARCH WITH PARTICULAR ATTENTION TO POLIOMYELITIS].
    BERDONDINI I; PANERO C
    Riv Clin Pediatr; 1964 Jan; 73():24-34. PubMed ID: 14201992
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 19. PRODUCTION OF HIGH-TITER ENTEROVIRUS ANTISERA IN BABOONS.
    OCAMPO AR; MELNICK JL
    Am J Hyg; 1964 May; 79():349-56. PubMed ID: 14159954
    [No Abstract]   [Full Text] [Related]  

  • 20. STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).
    VONKA V; TARABCAK M; JANDA Z
    Arch Gesamte Virusforsch; 1964; 14():169-76. PubMed ID: 14141577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.